Provectus Biopharmaceuticals, Inc. Share Price
Stocks
PVCT
US74373P1084
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0666 USD | -4.04% |
|
+7.94% | +19.14% |
| 25/06 | Provectus Biopharmaceuticals, Inc. Launches Veripure Open Science Program For Medical Research Access To PV-10 | CI |
| 19/06 | Provectus Biopharmaceuticals, Inc. - Shareholder/Analyst Call |
| Market Cap | 2.8Cr 2.45Cr 2.26Cr 2.12Cr 3.97Cr 264.04Cr 4.05Cr 27Cr 11Cr 130.5Cr 11Cr 10Cr 452.5Cr | P/E 2024 |
-10.6x | P/E 2025 | -4.33x |
|---|---|---|---|---|---|
| Enterprise Value | 3.07Cr 2.69Cr 2.48Cr 2.32Cr 4.36Cr 289.77Cr 4.45Cr 30Cr 12Cr 143.21Cr 12Cr 11Cr 496.59Cr | EV / Sales 2024 |
8,64,51,912x | EV / Sales 2025 | 7,80,13,766x |
| Free-Float |
92.21% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Provectus Biopharmaceuticals, Inc.
| 1 day | -4.04% | ||
| 1 week | +7.94% | ||
| Current month | +2.46% | ||
| 1 month | +8.47% | ||
| 3 months | +34.00% | ||
| 6 months | +11.37% | ||
| Current year | +19.14% |
| 1 week | 0.06 |  | 0.07 |
| 1 month | 0.06 | | 0.07 |
| Current year | 0.04 | | 0.07 |
| 1 year | 0.04 | | 0.1 |
| 3 years | 0.04 | | 0.22 |
| 5 years | 0.03 | | 0.22 |
| 10 years | 0.01 | | 0.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
Edward Pershing
CEO | Chief Executive Officer | 73 | 16/04/2024 |
Eric Wachter
CTO | Chief Tech/Sci/R&D Officer | 62 | 15/05/2012 |
Heather Raines
DFI | Director of Finance/CFO | 59 | 25/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 57 | 03/04/2017 | |
John Lacey
BRD | Director/Board Member | 78 | 27/04/2018 |
Edward Pershing
CHM | Chairman | 73 | 27/04/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05/06 | Fiscal year | Chief Executive Officer | -9,436 | 0.0022% | ||
| 28/05 | Free | Chief Executive Officer | 0 | 0% | ||
| 23/05 | Fiscal year | Chief Executive Officer | -32,089 | 0.0076% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.04% | +7.94% | -11.20% | -44.03% | 2.8Cr | |
| +0.33% | +1.37% | +63.66% | +126.38% | 5.56TCr | |
| +0.82% | +15.05% | +79.52% | +85.53% | 5.22TCr | |
| +1.36% | +0.36% | -14.52% | -13.83% | 2.31TCr | |
| -1.04% | +7.91% | +3.91% | +417.68% | 2.24TCr | |
| -0.18% | +7.20% | +31.37% | -13.62% | 1.73TCr | |
| -1.10% | +4.00% | +29.97% | -33.36% | 1.59TCr | |
| +2.89% | +5.51% | +25.42% | +186.30% | 1.38TCr | |
| -3.35% | +8.96% | +134.32% | +289.59% | 1.35TCr | |
| +1.31% | +0.53% | +27.83% | - | 1.24TCr | |
| Average | -0.30% | +5.09% | +37.03% | +111.18% | 2.26TCr | |
| Weighted average by Cap. | +0.26% | +5.13% | +48.49% | +122.66% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.62 0.54 0.5 0.47 0.88 58.22 0.89 5.99 2.32 28.77 2.32 2.27 99.77 | 0.34 0.29 0.27 0.25 0.48 31.71 0.49 3.26 1.26 15.67 1.26 1.23 54.34 |
| Net income | -47.62L -41.75L -38.49L -36.03L -67.57L -45Cr -68.97L -4.63Cr -1.79Cr -22Cr -1.79Cr -1.75Cr -77Cr | -54.31L -47.62L -43.89L -41.09L -77.06L -51Cr -78.66L -5.28Cr -2.04Cr -25Cr -2.04Cr -1.99Cr -88Cr |
| Net Debt | 28.77L 25.23L 23.25L 21.77L 40.82L 27Cr 41.67L 2.8Cr 1.08Cr 13Cr 1.08Cr 1.06Cr 47Cr | 27.27L 23.91L 22.04L 20.64L 38.7L 26Cr 39.5L 2.65Cr 1.03Cr 13Cr 1.02Cr 1Cr 44Cr |
Employees
6
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/26/26 | $0.0666 | -4.04% | 1,14,224 |
| 25/26/25 | $0.0694 | +1.53% | 60,818 |
| 24/26/24 | $0.0684 | -0.06% | 1,77,463 |
| 23/26/23 | $0.0684 | +3.95% | 2,64,225 |
| 22/26/22 | $0.0658 | +6.65% | 1,25,915 |
- Stock Market
- Stocks
- PVCT Stock
Select your edition
All financial news and data tailored to specific country editions
